A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation - Top-Institutions - MDSpire

A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation

  • By

  • Yung Lee

  • Ji Seok Park

  • Stephen Firkins

  • Sera Satoi

  • Vikash Fnu

  • Kyungran Justina Cho

  • Amit Bhatt

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Agilis Robotics
    Agilis Robotics

    Unknown, Unknown

    Key Differentiators

    • Robotics

  • #2

    Olympus
    Olympus

    Unknown, Unknown

    Key Differentiators

    • Medical Devices

  • #3

    Politecnico di Milano
    Politecnico di Milano

    Milan, Lombardy

    Key Differentiators

    • Engineering
    • Research

  • #4

    Institute for SMTs of the esophagus
    Institute for SMTs of the esophagus

    Unknown, Unknown

    Key Differentiators

    • Medical Research

  • #5

    Seoul National University Hospital
    Seoul National University Hospital

    Seoul, South Korea

    Key Differentiators

    • Healthcare

Original Source(s)

A novel bimanual endoluminal robotic platform compatible with standard gastroscopes for endoscopic submucosal dissection: preclinical feasibility and ergonomic evaluation

  • by Yung Lee, Ji Seok Park, Stephen Firkins, Sera Satoi, Vikash Fnu, Kyungran Justina Cho, Amit Bhatt

  • July 1, 2026

Related Content

ASCO26: Atish Choudhury, MD, PhD, A-DREAM/Alliance A032101

A-DREAM/Alliance A032101 study presented by Dana-Farber Cancer Institute's Dr. Atish Choudhury shows 41% of favorable responders to testosterone suppression plus androgen receptor pathway inhibitor remaining treatment-free with testosterone recovery at 18 months after treatment interruption.

  • July 1, 2026

  • 1 min
Repurposing tricyclic drugs as cancer therapeutics: comparative analysis of antitumorigenic effects of chlorpromazine, amitriptyline and imipramine

Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study